Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4695070012 | Pyronaridine tetraphosphate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4695071011 | Pyronaridine tetraphosphate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pyronaridine tetraphosphate | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Pyronaridine tetraphosphate | Is a | Substance with antimalarial mechanism of action (substance) | true | Inferred relationship | Some | ||
| Pyronaridine tetraphosphate | Has disposition (attribute) | Antimalarial (disposition) | true | Inferred relationship | Some | ||
| Pyronaridine tetraphosphate | Is modification of (attribute) | Pyronaridine (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Artesunate 60 mg and pyronaridine tetraphosphate 180 mg oral tablet | Has precise active ingredient | True | Pyronaridine tetraphosphate | Inferred relationship | Some | 1 |
| Artesunate 60 mg and pyronaridine tetraphosphate 180 mg oral tablet | Has basis of strength substance (attribute) | True | Pyronaridine tetraphosphate | Inferred relationship | Some | 1 |
| Product containing precisely artesunate 20 milligram and pyronaridine tetraphosphate 60 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has precise active ingredient | True | Pyronaridine tetraphosphate | Inferred relationship | Some | 1 |
| Product containing precisely artesunate 20 milligram and pyronaridine tetraphosphate 60 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | True | Pyronaridine tetraphosphate | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR